Skip to main content

RHUMBLINE ADVISERS

Position in ADAPY — Adaptimmune Therapeutics PLC

CIK 1115418 BOSTON, MA

Position in ADAPY

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$73
-$22 QoQ
Shares Held
3,661
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 1 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADAPY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ADAPY

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $73 3,661
2025-12-31 $95 3,661
2025-09-30 $746 5,743
2025-06-30 $2,047 8,533
2025-03-31 $3,607 18,313
2024-12-31 $10,644 19,748
2024-09-30 $18,202 19,160
2024-06-30 $16,302 16,721
2024-03-31 $11,252 7,122
2023-12-31 $4,688 5,912
2023-09-30 $4,353 5,582
2023-06-30 $5,163 5,582